Suchergebnisse - "Shiu, Kai-Keen"

PubPharm (54)

11

Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients : the PCF_SELECT consortium assay

enthalten in: NAR cancer | 2022

von Orlando, F. | Romanel, A. | Trujillo, B. | +117

12

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177) : final analysis of a randomised, open-label, phase 3 study

enthalten in: The Lancet. Oncology | 2022

von Diaz, L. | Shiu, K. | Kim, T. | +17

CommentIn: Lancet Oncol. 2022 Jun;23(6):e245. - PMID 35654062

13

Mutation Rate Evolution Drives Immune Escape In Mismatch Repair-Deficient Cancer

enthalten in: bioRxiv.org | 2022

von Kayhanian, H. | Barmpoutis, P. | Lakatos, E. | +26

14

Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer

enthalten in: bioRxiv.org | 2022

von Challoner, B. | Woolston, A. | Lau, D. | +36

15

Trifluridine/Tipiracil in Metastatic Colorectal Cancer : A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors

enthalten in: Clinical colorectal cancer | 2021

von Stavraka, C. | Pouptsis, A. | Synowiec, A. | +19

16

Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy : Results of the Randomized FOCUS4-N Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Adams, R. | Fisher, D. | Graham, J. | +19

CommentIn: J Clin Oncol. 2021 Nov 20;39(33):3656-3659. - PMID 34516761

17

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

enthalten in: Cancer cell | 2021

von Au, L. | Hatipoglu, E. | Robert de Massy, M. | +155

CommentIn: Cell Rep Med. 2021 Nov 16;2(11):100445. - PMID 34841292

18

Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade : Analysis of the KEYNOTE 177 Trial and Validation Cohorts

enthalten in: Gastroenterology | 2021

von Bortolomeazzi, M. | Keddar, M. | Montorsi, L. | +26

19

Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177) : an open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Andre, T. | Amonkar, M. | Norquist, J. | +17

20

Immunogenomic profile of colorectal cancer response to immune checkpoint blockade

enthalten in: bioRxiv.org | 2021

von Bortolomeazzi, M. | Keddar, M. | Montorsi, L. | +26